DM023 - Diabetes (with a history of CVD) on a statin (Retired v50 2025/26)
The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD). Not all of these may be present or selectable in all clinical systems.
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF).
Indicator definition
Indicator ID | Description |
DM023 | The percentage of patients with diabetes, on the register, and a history of CVD (excluding haemorrhagic stroke) who are currently treated with a statin. |
What do the business rules mean?
What adds patients in to eligibility?
Patients are eligible for the DM022 denominator if they:
- are on the Diabetes register
- have one of:
- CHD
- STIA
- PAD
- Familial hypercholesterolaemia
- Unresolved CKD
- do not have a coded history of a haemorrhagic stroke
How to achieve the indicator
To meet the criteria for DM023, eligible patients must have had:
- an issue of a statin in the 6 months before the end of the contract year
What will remove patients from eligibility?
- Patients who are coded for maximal tolerated cholesterol lowering therapy in the contract year
- have persisting statin contraindications ever or expiring statin contraindications in the contract year
- Patients for whom diabetes quality indicator care was unsuitable in the contract year
- Patients who chose not to receive a statin in the contract year
- Patients who chose not to receive diabetes quality indicator care in the contract year
- Patients who have been invited twice (at least 7 days apart) for review
- Patients who were diagnosed with diabetes in the last 3 months of the contract year
- Patients who were newly registered with the practice in the last 3 months of the contract year
If a patient achieves the
indicator at any point during the year, any exclusions that have also been
added are ignored.
SNOMED codes used in this indicator
The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD). Not all of these may be present or selectable in all clinical systems.
The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD). Not all of these may be present or selectable in all clinical systems.
Codes indicating the patient is on maximal tolerated cholesterol lowering treatment (CHOLMAX_COD)
SNOMED code | SNOMED code description |
407568002 | Patient on maximal tolerated lipid lowering therapy |
Statin contraindications (persisting) (XSTAT_COD)
SNOMED code | SNOMED code description |
293432006 | 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor adverse reaction |
293434007 | Adverse reaction caused by fluvastatin |
293435008 | Adverse reaction caused by pravastatin |
293433001 | Adverse reaction caused by simvastatin |
294970008 | Allergy to 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor |
294972000 | Allergy to fluvastatin |
294973005 | Allergy to pravastatin |
294971007 | Allergy to simvastatin |
16524331000119104 | History of rhabdomyolysis due to statin |
787206005 | Rhabdomyolysis due to statin |
Statin contraindications (expiring) (TXSTAT_COD)
SNOMED code | SNOMED code description |
134391005 | Statin not indicated |
413174003 | Statin not tolerated |
315363002 | Statins contraindicated |
Codes for diabetes quality indicator care unsuitable for patient (DMPCAPU_COD)
SNOMED code | SNOMED code description |
717421000000100 | Excepted from diabetes quality indicators - patient unsuitable |
Codes indicating the patient has chosen not to receive a statin prescription (STATINDEC_COD)
SNOMED code | SNOMED code description |
134396000 | Statin declined |
Codes indicating the patient has chosen not to receive diabetes quality indicator care (DMPCADEC_COD)
SNOMED code | SNOMED code description |
716031000000106 | Excepted from diabetes quality indicators - informed dissent |
Invite for diabetes care review codes (DMINVITE_COD)
| SNOMED code | SNOMED code description |
| 1109921000000106 | Quality and Outcomes Framework quality indicator-related care invitation |
| 1110921000000100 | Quality and Outcomes Framework diabetes mellitus quality indicator-related care invitation |
| 143401000000102 | Quality and Outcomes Framework diabetes mellitus quality indicator-related care invitation using preferred method of communication |
| 705072004 | Diabetes monitoring invitation by short message service text messaging |
1066911000000100 | Diabetes monitoring short message service text message first invitation |
1066921000000106 | Diabetes monitoring short message service text message second invitation |
1066931000000108 | Diabetes monitoring short message service text message third invitation |
1083111000000108 | Diabetes monitoring invitation email |
185756006 | Diabetes monitoring first letter |
185757002 | Diabetes monitoring second letter |
185758007 | Diabetes monitoring third letter |
185759004 | Diabetes monitoring verbal invite |
185760009 | Diabetes monitoring telephone invite |
310425007 | Diabetes monitoring invitation |